Consequences of Cisplatin Binding on Nucleosome Structure and Dynamics
- 22 December 2010
- journal article
- Published by Elsevier BV in Cell Chemical Biology
- Vol. 17 (12), 1334-1343
- https://doi.org/10.1016/j.chembiol.2010.10.018
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute (CA034992, CA034992)
- National Institutes of Health (RR-15301, RR-15301)
- Koch Fund
- Koch Institute for Integrative Cancer Research
- U.S. Department of Energy (DE-AC02-06CH11357, DE-AC02-06CH11357)
This publication has 55 references indexed in Scilit:
- Conformational analysis of nucleic acids revisited: CurvesNucleic Acids Research, 2009
- Inhibition of transcription by platinum antitumor compoundsMetallomics, 2009
- Platinum Drug Adduct Formation in the Nucleosome Core Alters Nucleosome Mobility but Not PositioningCell Chemical Biology, 2008
- A 1,2-d(GpG) Cisplatin Intrastrand Cross-Link Influences the Rotational and Translational Setting of DNA in NucleosomesJournal of the American Chemical Society, 2008
- Cisplatin Damage Overrides the Predefined Rotational Setting of Positioned NucleosomesJournal of the American Chemical Society, 2007
- Nucleosome Core Particles Containing a Poly(dA·dT) Sequence Element Exhibit a Locally Distorted DNA StructureJournal of Molecular Biology, 2006
- A genomic code for nucleosome positioningNature, 2006
- Cellular processing of platinum anticancer drugsNature Reviews Drug Discovery, 2005
- Theory of Nucleosome Corkscrew Sliding in the Presence of Synthetic DNA LigandsJournal of Molecular Biology, 2004
- NMR Solution Structure of a DNA Dodecamer Duplex Containing a cis-Diammineplatinum(II) d(GpG) Intrastrand Cross-Link, the Major Adduct of the Anticancer Drug CisplatinBiochemistry, 1998